1. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002;25:202–212.
2. U.S. Department of Agriculture, U.S. Department of Health and Human Services. Nutrition and your health: dietary guidelines for Americans, 3rd ed. Hyattsville, MD: USDA’s Human Nutrition Information Service, 1990.
3. U.S. Department of Agriculture. The food guide pyramid. Hyattsville, MD: USDA’s Human Nutrition Information Service, 1992.
4. Willett WC. Diet and health: what should we eat? Science 1994; 264:532.
5. American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 1994;17: 519.
6. Franz MJ, Horton ES, Bantle JP, et al. Nutrition principles for the management of diabetes and related complications. Diabetes Care 1994;17:490.
7. Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285: 2486–2497.
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin treated diabetes mellitus. N Engl J Med 1993;329:977.
9. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837.
10. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352:854.
11. Stamler J, Vaccaro O, Neaton JD, et al., for the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434.
12. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393.
13. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790.
14. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343.
15. Katan MB, Willett WC, Grundy SM. Beyond low fat diets. N Engl J Med 1997;337:563.
16. Gannon MC, Nuttall JA, Nuttall FQ. Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal. Am J Clin Nutr 2002;76:1016–1022.
17. Bantle JP, Laine CW, Thomas JW. Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects. JAMA 1986; 256:3241.
18. Bantle JP, Swanson JE, Thomas W, et al. Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care 1992;15:1468.
19. Swanson JE, Laine DC, Thomas W, et al. Metabolic effects of dietary fructose in healthy subjects. Am J Clin Nutr 1992;55:851.
20. Crapo PA, Kolterman OG, Henry RR. Metabolic consequence of two-week fructose feeding in diabetic subjects. Diabetes Care 1986; 9:111.
21. Thorburn AW, Crapo PA, Beltz WF, et al. Lipid metabolism in non–insulin-dependent diabetes: effects of long-term treatment with fructose-supplemented mixed meals. Am J Clin Nutr 1989;50:1015.
22. Holman RR, Cull CA, Turner RC. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 1999; 22:960.
23. Creutzfeldt W. Introduction. In: Creutzfeldt W, Folsch UR, eds. Delaying absorption as a therapeutic principle in metabolic diseases. New York: Thieme-Stratton, 1983:1.
24. Jenkins DJA, Wolever TMS, Ocana AM, et al. Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuous sipping. Diabetes 1990;39:775.
25. Jungas RL, Ball GE. Studies on the metabolism of adipose tissue. XII. The effects of insulin and epinephrine on fatty acid and glycerol production in the presence and absence of glucose. Biochemistry 1963;2:383.
26. Randle PJ, Garland PB, Hales CN, et al. The glucose-fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785.
27. Ceriello A, Bortolotti N, Crescentini A, et al. Antioxidant defences are reduced during the oral glucose tolerance test in normal and non–insulin-dependent diabetic subjects. Eur J Clin Invest 1998;28: 529.
28. Ceriello A, Bortolotti N, Motz E, et al. Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. Metabolism 1999;48:1503.
29. Rao AV, Agarwal S. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutr Res 1999;19:305.
30. Sharma A, Kharb S, Chugh SN, et al. Effect of glycemic control and vitamin E supplementation on total glutathione content in non–insulin-dependent diabetes mellitus. Ann Nutr Metab 2000;44:11.
31. Paolisso G, D’Amore A, Giugliano D, et al. Pharmacological doses of vitamin E improve insulin action in healthy subjects and non–insulin-dependent diabetic patients. Am J Clin Nutr 1993;57:650.
32. Jenkins DJA, Wolever TMS, Taylor RH, et al. Reply to letter by Abraira and Lawrence. Am J Clin Nutr 1983;37:153.
33. Staub H. Untersuchenuber den Zuckerstoffwechsel des Menschen: I. Mitteilung. Z Klin Med 1921;91:44.
34. Traugott K. Uber das Verhalten des Blutzuckerspiegels bei wiederholten und verschiedener Art enteraler zuckerzurzufuhr und dessen Bedeutung fur die leberfunktion. Klin Wochenschr 1922;1:892.
35. Jenkins DJA, Wolever TMS, Taylor RH, et al. Slow release dietary carbohydrate improves second meal tolerance. Am J Clin Nutr 1982; 35:1339.
36. Collier GR, Wolever TMS, Jenkins DJA. Concurrent ingestion of fat and reduction in starch content impairs carbohydrate tolerance to subsequent meals. Am J Clin Nutr 1987;45:963.
37. Jenkins DJA, Wolever TMS, Nineburn R, et al. Improved glucose tolerance four hours after taking guar with glucose. Diabetologia 1980;19:21.
38. Abraira C, Lawrence AM. Dietary carbohydrate and second meal glycemic response. Am J Clin Nutr 1983;37:152.
39. Nuttall FQ, Mooradian AD, Gannon MC, et al. Effect of protein ingestion on glucose and insulin response to a standardized oral glucose load. Diabetes Care 1984;7:465.
40. Collier G, O’Dea K. The effect of coingestion of fat on the glucose, insulin and gastric inhibitory polypeptide responses to carbohydrate and protein. Am J Clin Nutr 1983;37:941.
41. Estrich D, Ravnick A, Schlierf G, et al. Effects of co-ingestion of fat and protein upon carbohydrate induced hyperglycaemia. Diabetes 1967;16:232.
42. Gerich JE. Glucose counter regulation and its impact on diabetes mellitus. Diabetes 1988;37:1608.
43. Wolever TM, Bentum-Williams A, Jenkins DJ. Physiological modulation of plasma free fatty acid concentrations by diet. Metabolic implications in nondiabetic subjects. Diabetes Care 1995;18:962.
44. Dupres J, Behme MT, Hramiak IM, et al. Hepatic extraction of insulin after stimulation of secretion with oral glucose or parenteral nutrients. Metabolism 1993;42:921.
45. Radziuk J, McDonald TJ, Rubenstein D, et al. Initial splanchnic extraction of ingested glucose in normal man. Metabolism 1978;27:657.
46. Ellis A. Increased carbohydrate tolerance in diabetes following hourly administration of glucose and insulin over long periods. Q J Med 1934;27:137.
47. Fabry P, Tepperman J. Meal frequency: a possible factor in human pathology. Am J Clin Nutr 1970;25:1059.
48. Gwinup G, Byron R, Roush W, et al. Effect of nibbling versus gorging on glucose tolerance. Lancet 1963;2:165.
49. Cohn C. Feeding patterns and some aspects of cholesterol metabolism. Fed Proc 1964;23:76.
50. Jagannathan SN, Connell WF, Beveridge JMR. Effect of gourmandizing and semicontinuous eating of equicaloric amounts of formula type high-fat diets on plasma cholesterol and triglyceride levels in human volunteer subjects. Am J Clin Nutr 1964;15:90.
51. Bray GA. Lipogenesis in human adipose tissue: some effects of nibbling and gorging. J Clin Invest 1972;51:537.
52. Jenkins DJA, Wolever TMS, Vuksan V, et al. “Nibbling versus gorging”: metabolic advantages of increased meal frequency. N Engl J Med 1989;321:929.
53. Jenkins DJA, Ocana A, Jenkins A, et al. Metabolic advantages of spreading the nutrient load: effects of increased meal frequency in non–insulin-dependent diabetes. Am J Clin Nutr 1992;55: 461.
54. Bertelsen J, Christiansen C, Thomsen C, et al. Effect of meal frequency on blood glucose, insulin, and free fatty acids in NIDDM subjects. Diabetes Care 1993;16:3.
55. Arnold LM, Ball MJ, Duncan AW, et al. Effect of isoenergetic intake of three or nine meals on plasma lipoproteins and glucose metabolism. Am J Clin Nutr 1993;57:446.
56. McGrath SA, Gibney MJ. Effects of altered frequency of eating on plasma lipids of free-living healthy males on normal self-selected diets. Eur J Nutr 1994;48:402.
57. Edelstein SL, Barrett-Connor EL, Wingard DL, Cohn BA. Increased meal frequency associated with decreased cholesterol concentrations: Rancho Bernardo, CA, 1984–1987. Am J Clin Nutr 1992;55:664.
58. Jenkins DJA, Khan A, Jenkins AL, et al. The effect of nibbling versus gorging on cardiovascular risk factors: serum uric acid and blood lipids. Metabolism 1995;44:549.
59. Jones PJH, Leitch CA, Pederson RA. Meal frequency effects of plasma hormone concentrations and cholesterol synthesis in humans. Am J Clin Nutr 1993;57:868.
60. Lakshmanan MR, Nepokroeff CM, Ness GC, et al. Stimulation by insulin of rat liver beta-hydroxy-beta-methylglutaryl coenzyme-A reductase and cholesterol-synthesizing activities. Biochem Biophys Res Commun 1973;50:704.
61. Arnold L, Ball M, Mann J. Metabolic effects of alterations in meal frequency in hypercholesterolemic individuals. Atherosclerosis 1994; 108:167.
62. Mann J. Meal frequency and plasma lipids and lipoproteins. Br J Nutr 1997;77(suppl):83.
63. Faschini F, Chen YDI, Hollenbeck CB, et al. Relationship between insulin resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration. JAMA 1991; 266:3008.
64. Belko AZ, Barbieri TF. Effect of meal size and frequency on the thermic effect of food. Nutr Res 1987;7:237.
65. Kinabo JL, Durnin JV. Effect of meal frequency on the thermic effect of food in women. Eur J Clin Nutr 1990;44:389.
66. Tai MM, Eastillo P, Pi-Sunyer FX. Meal size and frequency: effect on the thermic effects of food. Am J Clin Nutr 1991;54:783.
67. Molnar D. The effect of meal frequency on postprandial thermogenesis in obese children. Padiatrie Padologi 1992;27:177.
68. Leblanc J, Mercier I, Nadeau A. Components of postprandial thermogenesis in relation to meal frequency in humans. Can J Physiol Pharmacol 1993;71:879.
69. Bellisle F, McDevitt R, Prentice AM. Meal frequency and energy balance. Br J Nutr 1997;77(suppl):57.
70. Jenkins DJA, Wolever TMS, Leeds AR, et al. Dietary fibres, fibre analogues and glucose tolerance: importance of viscosity. BMJ 1978; 1:1392.
71. Jenkins DJA, Reynolds D, Leeds AR, et al. Hypocholesterolemic action of dietary fiber unrelated to fecal bulking effect. Am J Clin Nutr 1979;32:2430.
72. Anderson JW, Zettwoch N, Feldman T, et al. Cholesterol lowering effects of psyllium hydrophilic mucilloid for hypercholesterolemic men. Arch Intern Med 1988;148:292.
73. Anderson JW, Gastaform NJ. Hypocholesterolemic effects of oat and bean products. Am J Clin Nutr 1988;48:749.
74. Kay RM, Truswell AS. Effect of citrus pectin on blood lipids and fecal steroid excretion in men. Am J Clin Nutr 1977;30: 171.
75. Miettenen TA, Tarpila S. Effect of pectin on serum cholesterol, fecal bile acids and biliary lipids in normolipidaemic and hyperlipidaemic individuals. Clin Chim Acta 1979;79:471.
76. Jenkins DJA, Wolever TMS, Rao AV, et al. Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. N Engl J Med 1993;329:21.
77. Jenkins DJA, Leeds AR, Gaosull MA, et al. Unabsorbable carbohydrates and diabetes: decreased post prandial hyperglycemia. Lancet 1976;2:172.
78. Nuttall FQ. Dietary fiber in the management of diabetes. Diabetes 1993;42:503.
79. Landin K, Holm G, Tengborn L, et al. Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr 1992;56:1061.
80. Vuorinen-Markkola H, Sinisalo M, Koivisto VA. Guar gum in insulin dependent diabetes: effect on glycemic control and serum lipoproteins. Am J Clin Nutr 1992;56:1056.
81. Groop P-H, Aro A, Stenman S, et al. Long term effects of guar gum in subjects with non-insulin dependent diabetes mellitus. Am J Clin Nutr 1993;58:513.
82. Morris JN, Marr JW, Clayton DG. Diet and heart: a postscript. BMJ 1977;2:1307–1314.
83. Liu S, Stampfer MJ, Hu FB, et al. Whole-grain consumption and risk of coronary heart disease: results from the Nurses’ Health Study. Am J Clin Nutr 1999;70:412–419.
84. Meyer KA, Kushi LH, Jacobs DR Jr, et al. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 2000;71:921–930.
85. Liu S, Manson JE, Stampfer MJ, et al. A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women. Am J Public Health 2000;90:1409–1415.
86. Bosello O, Ostuzzi R, Armellini F, et al. Glucose tolerance and blood lipids in bran-fed patients with impaired glucose tolerance. Diabetes Care 1980;3:46–49.
87. Brodribb AJ, Humphreys DM. Diverticular disease: three studies. Part III. Metabolic effect of bran in patients with diverticular disease. BMJ 1976;1:428–430.
88. Villaume C, Beck B, Gariot P, et al. Long-term evolution of the effect of bran ingestion on meal-induced glucose and insulin responses in healthy man. Am J Clin Nutr 1984;40:1023–1026.
89. Fung TT, Hu FB, Pereira MA, et al. Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr 2002;76:535–540.
90. Pereira MA, Jacobs DR Jr, Pins JJ, et al. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr 2002;75:848–855.
91. Jenkins DJ, Kendall CW, Augustin LS, et al. Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care 2002;25:1522–1528.
92. Jenkins DJA, Wolever TMS, Taylor RH, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981;34:362.
93. Jenkins DJA, Wolever TMS, Taylor RH, et al. Rate of digestion of foods and postprandial glycemia in normal and diabetic subjects. BMJ 1980;2:14.
94. Crapo PA, Reaven G, Olefsky J. Post-prandial plasma glucose and insulin responses to different complex carbohydrates. Diabetes 1977; 26:1178.
95. Bornet FRJ, Costagliole D, Rizkalla SW, et al. Insulinemic and glycemic indexes of six starch-rich foods taken alone and in a mixed meal by type 2 diabetes. Am J Clin Nutr 1987;45:588.
96. Collier GR, Wolever TMS, Wong GS, et al. Prediction of glycemic response to mixed meals in non-insulin dependent diabetic subjects. Am J Clin Nutr 1986;44:349.
97. Jenkins DJA, Wolever TMS, Kalmusky J, et al. Low glycemic index diet in hyperlipidemia: Use of traditional starchy foods. Am J Clin Nutr 1987;46:66.
98. Hollenbeck CB, Coulston AM, Reaven GM. Comparison of plasma glucose and insulin responses to mixed meals of high, intermediate and low-glycemic potential. Diabetes Care 1988;11:323.
99. Laine DC, Thomas W, Levitt MD, et al. Comparison of predictive capabilities of diabetic exchange lists and glycemic index of foods. Diabetes Care 1987;19:387.
100. Nuttall FQ, Mooradian AD, DeMarais R, et al. The glycemic effect of different meals approximately isocaloric and similar in protein, carbohydrate and fat content as calculated using the ADA exchange lists. Diabetes Care 1983;6:432.
101. Fukagawa NK, Anderson JW, Hageman G, et al. High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. Am J Clin Nutr 1990;52:524–528.
102. Frost G, Keogh B, Smith D, et al. The effect of low-glycemic carbohydrate on insulin and glucose response in vivo and in vitro in patients with coronary heart disease. Metabolism 1996;45:669.
103. Collier GR, Guidici S, Kalmusky J, et al. Low glycemic index starchy foods improve glucose control and lower serum cholesterol in diabetic children. Diabetes Nutr Metab 1988;1:11.
104. Fontvieille AM, Acosta M, Rizkalla SW, et al. A moderate switch from high to low glycemic index foods for 3 weeks improves the metabolic control of type 1 (IDDM) diabetic subjects. Diabetes Nutr Metab 1988;1:139.
105. Lafrance L, Rabasa-Lhoret R, Poisson D, et al. Effects of different glycaemic index foods and dietary fibre intake on glycaemic control in type 1 diabetic patients on intensive insulin therapy. Diabetes Med 1998;15:972.
106. Giacco R, Parillo M, Rivellese AA, et al. Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care 2000;23:1461.
107. Gilbertson HR, Brand-Miller JC, Thorburn AW, et al. The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes. Diabetes Care 2001;24:1137.
108. Jenkins DJA, Wolever TMS, Buckley G, et al. Low glycemic-index starchy foods in the diabetic diet. Am J Clin Nutr 1988;48:248.
109. Brand JC, Calagiuri S, Crossman S, et al. Low-glycemic index foods improve long-term glycemic control in NIDDM. Diabetes Care 1991;14:95.
110. Wolever TMS, Jenkins DJA, Vuksan V, et al. Beneficial effect of low-glycemic index diet in overweight NIDDM subjects. Diabetes Care 1992;15:562.
111. Wolever TMS, Jenkins DJA, Vuksan V, et al. Beneficial effect of a low glycemic index diet in type 2 diabetes. Diabetes Med 1992;9: 451.
112. Frost G, Wilding J, Beecham J. Dietary advice based on the glycemic index improves metabolic control of diabetic patients over five weeks. Diabetes Med 1992;9:440.
113. Jarvi AE, Karlstrom BE, Granfeldt YE, et al. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care 1999; 22:10.
114. Luscombe ND, Noakes M, Clifton PM. Diets high and low in glycemic index versus high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM. Eur J Clin Nutr 1999; 53:473.
115. Fontvieille AM, Rizkalla SW, Penfornis A, et al. The use of low glycemic index foods improves metabolic control of diabetic patients over five weeks. Diabetes Med 1992;9:444.
116. Calle-Pascual AL, Gomey V, Leon E, et al. Foods with a low glycemic index do not improve glycemic control of both type 1 and type 2 diabetic patients after one month of therapy. Diabetes Metab 1988;14:629.
117. Brand-Miller J, Colagiuri S, Hayne S, et al. Low glycaemic index diets in the management of diabetes: a meta-analysis of 14 randomised controlled trials. (submitted for publication).
118. Wolever TM. The glycemic index: flogging a dead horse? Diabetes Care 1997;20:452.
119. Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997;20:545.
120. Salmeron J, Manson JE, Stampfer MJ, et al. Dietary fiber, glycemic load, and risk of non–insulin-dependent diabetes mellitus in women. JAMA 1997;277:472.
121. Liu S, Willett WC, Stampfer MJ, et al. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr 2000;71:1455.
122. Stampfer MJ, Hu FB, Manson JE, et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000;343:16.
123. Liu S, Manson JE, Stampfer MJ, et al. Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr 2001;73:560.
124. Frost G, Leeds AA, Dore CJ, et al. Glycaemic index as a determinant of serum HDL-cholesterol concentration. Lancet 1999;353:1045.
125. Ford ES, Liu S. Glycemic index and serum high-density lipoprotein cholesterol concentration among US adults. Arch Intern Med 2001;161:572.
126. Ludwig DS, Majzoub JA, Al-Zahrani A, et al. High glycemic index foods, overeating, and obesity. Pediatrics 1999;103:E26.
127. Brand-Miller JC, Holt SH, Pawlak DB, et al. Glycemic index and obesity. Am J Clin Nutr 2002;76(suppl):281.
128. Holt S, Brand J, Soveny C, et al. Relationship of satiety to postprandial glycaemic, insulin and cholecystokinin responses. Appetite 1992; 8:129.
129. Mensink RP, Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoproteins in healthy men and women. Lancet 1987;1:122–125.
130. Coulston AM, Hollenbeck CB, Swislolocki MD, et al. Persistence of hypertriacylglycerolemic effect of low-fat high-carbohydrate diets in NIDDM patients. Diabetes Care 1989;12:94–101.
131. Garg A, Bantle JP, Henry KR, et al. Effects of varying carbohydrate content of diet in patients with non–insulin-dependent diabetes mellitus. JAMA 1994;271:1421.
132. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8–15.
133. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996;276:882–888.
134. Vega GL, Grundy SM. Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease. Curr Opin Lipidol 1996;7:209–216.
135. Brand Miller JC. The importance of glycemic index in diabetes. Am J Clin Nutr 1994;59(suppl):747–752.
136. Heilbronn LK, Noakes M, Clifton PM. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care 1999;22:889–895.
137. Jenkins DJ, Taylor RH, Goff DV, et al. Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes 1981;30: 951.
138. Chiasson JL, Josse RG, Hunt JA, et al. Efficacy of acarbose in the treatment of patients with non–insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med 1994;121: 928.
139. Rodger NW, Chiasson JL, Josse RG, et al. Clinical experience with acarbose: results of a Canadian multicentre study. Clin Invest Med 1995;18:318.
140. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072–2077.
141. Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002;287: 2414–2423.
142. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836.
143. Liu S, Manson JE, Buring JE, et al. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002;75: 492.
144. Rao AV, Agarwal S. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutr Res 1999;19:305.
145. Ceriello A, Bortolotti N, Motz E, et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998;21:1529.
146. Paolisso G, D’Amore A, Giugliano D, et al. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non–insulin-dependent diabetic patients. Am J Clin Nutr 1993;57: 650.